Miscellaneous dermatological conditions:
Indications for: ESKATA
Raised seborrheic keratoses.
Adult Dosage:
For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.
Children Dosage:
Not applicable.
ESKATA Warnings/Precautions:
Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.
ESKATA Classification:
Oxidizing agent.
Adverse Reactions:
Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.
Generic Drug Availability:
NO
How Supplied:
Pen applicator (1.5mL, 2.2mL)—1, 3, 12
